01 February 2006
Asthma , COPD, Allergy

On Wednesday 22 February, the European Parliament’s Environment Committee is due to vote on the European Commission Proposal for the EU 7th Framework Programme for Research and EFA has sent each member of the committee a letter outlining the impact of allergy, asthma and COPD on the everyday lives and mortality of people living in Europe and calling upon them prioritizing these diseases in the text.

We will keep you informed on the results of the vote.

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team